Cityphar SA
3.9 FTECityphar reported total assets of €2.22m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 3.9 full-time equivalents.
The score of Cityphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -8 % Total assets -12 % Headcount (avg FTE) -33 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cityphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 15 Nov 2024
- Year ended 31 Dec 2022filed on 25 Mar 2024
- Year ended 31 Dec 2021filed on 23 Dec 2022
Cityphar's financial analysis
- Solvency33.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cityphar
Cityphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0422.011.960
- VAT number
- BE0422011960
- Peppol
- Registered · 0208:0422011960 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Oct 1981
- Registered office
- 1050 Ixelles
- Size
- Micro · 3.9 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Cityphar (SA) has been based in Ixelles since 1981, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 82,891 € and equity of 737,505 €; its revenue is not published. With 3.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 33.2%, below the median of its sector (37.8%).
Companies similar to Cityphar
Companies in the same business, of comparable size and area, outside its group.
- Nagels Retail sale of pharmaceutical products Stabroek · balance sheet €2.22m
- Pharmacie Carlier-Thonet Retail sale of pharmaceutical products Herstal · balance sheet €2.22m
- Apotheek Cindy Nachtergaele Retail sale of pharmaceutical products Kruisem · balance sheet €2.22m
- Omnimed Retail sale of pharmaceutical products Kalmthout · balance sheet €2.22m
- BA Pharma Retail sale of pharmaceutical products Aiseau-Presles · balance sheet €2.21m
- Alphar Braine-LE-Comte Retail sale of pharmaceutical products Braine-le-Comte · balance sheet €2.21m
- F. Rodenbach Retail sale of pharmaceutical products Zulte · balance sheet €2.25m
- Almey-De Groote Retail sale of pharmaceutical products Kaprijke · balance sheet €2.16m
Frequently asked questions about Cityphar
What is the revenue of Cityphar?
Cityphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cityphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0422011960 for Cityphar, if the company is VAT-registered. Its company number (CBE) is 0422.011.960.
Where is the registered office of Cityphar?
According to the CBE register, the registered office of Cityphar is in 1050 Ixelles.
What is the equity of Cityphar?
At the close of the 2025 financial year, the equity of Cityphar amounts to 737,505 €, a solvency of 33.2% of total assets.
How many people work at Cityphar?
3.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Cityphar?
The register lists 7 active mandates at Cityphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cityphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →